Industry leaders in pharma and MedTech are urging the government to establish a structured funding framework for R&D ahead of the Union Budget 2026. They emphasize the need for policy changes to reduce cost disadvantages, nurture local innovation, and promote preventive healthcare to achieve India’s Viksit Bharat vision.